Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Byrna Technologies Inc (BYRN) vs Centene Corp (CNC) Price & Performance

Byrna Technologies IncTrade
Centene CorpTrade

Price performance (Past 24H)

Key statistics

Byrna Technologies Inc vs Centene Corp — how do they compare? Byrna Technologies Inc trades at $3.57 (market cap $80.33M), while Centene Corp trades at $66.58 (market cap $33.93B). The key difference: Centene Corp is far larger — about 422.4× Byrna Technologies Inc's market cap, and Centene Corp is trading nearer its 52-week high, Byrna Technologies Inc nearer its low. Which is the better fit depends on your goals.

BYRNCNC
Market Cap
$80.33M$33.93B
Sector
TechnologyHealth
52-Week High
$27.63$68.72
52-Week Low
$3.54$25.21
Enterprise Value
$71.94M$26.56B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Byrna Technologies Inc

BYRN trades at $3.82, down 1.16% today, with a bearish technical signal from moving averages. Recent Q2 2026 results showed a significant miss with a $0.44 EPS loss versus -$0.10 expected, amid a 42.5% revenue decline. The company is undergoing a marketing reset and acquired HERO Defense Systems to expand its product portfolio. Net income margin turned negative at -3.39% for 2026, though gross margin remains strong at 52.51%.

Outlook is cautious due to execution risks in sales turnaround efforts. Analyst consensus is bullish with 71% buy ratings, but near-term challenges in e-commerce traffic and conversion pose headwinds. The stock's valuation appears reasonable with P/S of 0.76, but profitability concerns and ongoing legal investigations present substantial risks for investors.

Centene Corp

Centene Corporation (CNC) trades at $68.29, up 1.4% with strong technical momentum and bullish moving average signals. The stock shows impressive 66% YTD gains, supported by recent contract renewals and margin recovery initiatives. Despite negative 2025 net income of -$6.67B, valuation metrics remain attractive with P/E of 8.06 and P/S of 0.17. Analyst consensus is strongly bullish with 61% buy ratings and $66.07 price target.

Centene presents a compelling value opportunity with low valuation multiples and strong operational cash flow of $5.09B. Key risks include ongoing margin pressure and Medicaid contract dependency. The company's AI-driven cost controls and recent Illinois Medicaid renewal provide catalysts for earnings recovery, though healthcare regulatory changes remain a concern for long-term stability.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Byrna Technologies Inc

Byrna Technologies specializes in less-lethal personal security devices. It develops and manufactures innovative handheld launchers and projectiles designed for self-defense, law enforcement, and private security use.

Read more on BYRN

About Centene Corp

Centene is a managed-care organization focused on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of September 2021, mostly in Medicaid (68% of membership), the individual exchanges (10%), Medicare Advantage (6%), and the balance in Tricare (West region), correctional facility, and international plans. The company also serves 4 million users through the Medicare Part D pharmaceutical program.

Read more on CNC